Magnus Johnsson (M Johnsson)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 7

Top Topics

Disease Activity

Cerebrospinal Fluid

Multiple Sclerosis

Top Venues

Multiple sclerosis (Houndmills, Basingstoke, England)

Annals of clinical and translational neurology

This page only lists publications with an associated author ORCID identifier.

Publications

Magnus Johnsson, Y T Stenberg, H H Farman, K Blennow, H Zetterberg, C Malmeström, Sofia Sandgren, Igal Rosenstein, Jan N Lycke, M Axelsson, Lenka Novakova
Serum neurofilament light for detecting disease activity in individual patients in multiple sclerosis: A 48-week prospective single-center study. Multiple sclerosis (Houndmills, Basingstoke, England) 30 (6) (2024)
Magnus Johnsson, Y T Stenberg, H H Farman, K Blennow, H Zetterberg, C Malmeström, Sofia Sandgren, Igal Rosenstein, Jan N Lycke, M Axelsson, Lenka Novakova
Serum neurofilament light for detecting disease activity in individual patients in multiple sclerosis: A 48-week prospective single-center study. Multiple sclerosis (Houndmills, Basingstoke, England) 30 (6) (2024)
Magnus Johnsson, Y T Stenberg, H H Farman, K Blennow, H Zetterberg, C Malmeström, Sofia Sandgren, Igal Rosenstein, Jan N Lycke, M Axelsson, Lenka Novakova
Serum neurofilament light for detecting disease activity in individual patients in multiple sclerosis: A 48-week prospective single-center study. Multiple sclerosis (Houndmills, Basingstoke, England) 30 (6) (2024)
Magnus Johnsson, Y T Stenberg, H H Farman, K Blennow, H Zetterberg, C Malmeström, Sofia Sandgren, Igal Rosenstein, Jan N Lycke, M Axelsson, Lenka Novakova
Serum neurofilament light for detecting disease activity in individual patients in multiple sclerosis: A 48-week prospective single-center study. Multiple sclerosis (Houndmills, Basingstoke, England) (2024)
Magnus Johnsson, Y T Stenberg, H H Farman, K Blennow, H Zetterberg, C Malmeström, Sofia Sandgren, Igal Rosenstein, Jan N Lycke, M Axelsson, Lenka Novakova
Serum neurofilament light for detecting disease activity in individual patients in multiple sclerosis: A 48-week prospective single-center study. Multiple sclerosis (Houndmills, Basingstoke, England) 30 (6) (2024)
Magnus Johnsson, Fredrik Asztely, Susanne Hejnebo, Markus Axelsson, Clas Malmeström, Torbjörn Olausson, Jan N Lycke
SARS-COV-2 a trigger of myelin oligodendrocyte glycoprotein-associated disorder. Annals of clinical and translational neurology 9 (8) (2022)
Magnus Johnsson, Helen H Farman, Kaj Blennow, Henrik Zetterberg, Clas Malmeström, Markus Axelsson, Jan N Lycke
No increase of serum neurofilament light in relapsing-remitting multiple sclerosis patients switching from standard to extended-interval dosing of natalizumab. Multiple sclerosis (Houndmills, Basingstoke, England) 28 (13) (2022)